Description: Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Home Page: www.insulet.com
100 Nagog Park
Acton,
MA
01720
United States
Phone:
978 600 7000
Officers
Name | Title |
---|---|
Dr. James R. Hollingshead Ph.D. | President, CEO & Director |
Ms. Lauren Budden | Group VP, Chief Accounting Officer & Controller |
Mr. Mark Field | Senior VP & CTO |
Mr. John Wodick Kapples J.D. | Senior VP & General Counsel |
Mr. Eric Benjamin | Executive VP, Chief Product & Customer Experience Officer |
Ms. Ana Maria Chadwick | Executive VP, CFO & Treasurer |
Mr. Prem Singh | Senior Vice President of Global Operations |
June Lazaroff | Senior Director of Investor Relations |
Ms. Laetitia Cousin | Senior VP of Regulatory Affairs, Quality Assurance & Compliance |
Angela Geryak Wiczek | Senior Director of Corporate Communications |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 68.9655 |
---|---|
Trailing PE: | 45.6577 |
Price-to-Book MRQ: | 16.8292 |
Price-to-Sales TTM: | 9 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 3000 |